Anna Pastra-Bonaterra
Barcelona, CT 08035, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy.
Journal: Alzheimer's research & therapy
Published: April 29, 2024
Apolipoprotein J protects cardiomyocytes from lipid-mediated inflammation and cytotoxicity induced by the epicardial adipose tissue of diabetic patients.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 06, 2024
Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy.
Journal: Frontiers in aging neuroscience
Published: December 30, 2022
Therapeutic effect of human ApoA-I-Milano variant in aged transgenic mouse model of Alzheimer's disease.
Journal: British journal of pharmacology
Published: July 11, 2022
Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study.
Journal: International journal of molecular sciences
Published: February 24, 2022
MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
Journal: Acta neuropathologica communications
Published: September 02, 2021
Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease.
Journal: Brain pathology (Zurich, Switzerland)
Published: March 08, 2021
Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage.
Journal: Journal of clinical medicine
Published: January 07, 2021
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.
Journal: Frontiers in neurology
Published: September 06, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026